Invention Grant
- Patent Title: RNA for treatment of autoimmune diseases
-
Application No.: US16500005Application Date: 2018-04-10
-
Publication No.: US11701413B2Publication Date: 2023-07-18
- Inventor: Ugur Sahin , Sebastian Kreiter , Christina Krienke , Jutta Petschenka , Lena Mareen Kranz , Mustafa Diken
- Applicant: BioNTech SE , TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH
- Applicant Address: DE Mainz
- Assignee: BioNTech SE,TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH
- Current Assignee: BioNTech SE,TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH
- Current Assignee Address: DE Mainz; DE Mainz
- Agency: Ballard Spahr LLP
- Priority: WO TEP2017058651 2017.04.11
- International Application: PCT/EP2018/059188 2018.04.10
- International Announcement: WO2018/189193A 2018.10.18
- Date entered country: 2019-10-01
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61P37/06 ; C12N15/11 ; C12N15/117
Abstract:
The present invention relates to non-immunogenic RNA. This RNA forms the basis for the development of therapeutic agents for inducing tolerance towards an autoantigen and thus, for the treatment of autoimmune diseases.
Public/Granted literature
- US20200061166A1 RNA FOR TREATMENT OF AUTOIMMUNE DISEASES Public/Granted day:2020-02-27
Information query
